Biomarin Pharmaceutical Inc

NASDAQ: BMRN
$92.06
+$2.57 (+2.9%)
Closing price April 23, 2024
BioMarin Pharmaceutical Inc. specializes in creating innovative treatments for individuals facing serious and life-threatening rare diseases. With a portfolio that includes enzyme replacement therapies like Vimizim for mucopolysaccharidosis and Naglazyme for MPS VI, BioMarin stands out in the pharmaceutical field. The company also offers Kuvan for phenylketonuria, Palynziq to manage blood phenylalanine levels, Brineura for Batten disease, Voxzogo for achondroplasia, and Aldurazyme for issues related to the enzyme alpha-L-iduronidase. Additionally, BioMarin is developing Roctavian for severe hemophilia A, demonstrating its commitment to addressing unmet medical needs worldwide. Founded in 1996, BioMarin is headquartered in San Rafael, California.

Wednesday's Top Analysts Upgrades and Downgrades: Arista Networks, Colgate-Palmolive, Expedia, Global Payments, Huntsman, ON Semiconductor, ZoomInfo and More
Wednesday's top analyst upgrades and downgrades included Academy Sports & Outdoors, Arista Networks, Colgate-Palmolive, Expedia, Global Payments, Huntsman, InMode, ON Semiconductor and Zoominfo...
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Amgen, Boeing, Carvana, Enterprise Products Partners, Johnson Controls, Nvidia, PayPal, PG&E, T-Mobile, Uber and More
Tuesday's top analyst upgrades and downgrades included Amgen, Array Technologies, Boeing, Carvana, DocuSign, Enterprise Products Partners, Fiserv, Johnson Controls, Monster Beverage, Nvidia, PayPal,...
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: Amgen, Harley-Davidson, Hertz, Las Vegas Sands, Meta Platforms, PayPal, Pinterest, T-Mobile, Visa and More
Friday's top analyst upgrades and downgrades included Amgen, Amphenol, Harley-Davidson, Hertz Global, Las Vegas Sands, Masco, Meta Platforms, NXP Semiconductors, Oshkosh, PayPal, Pinterest,...
Lee Jackson
Published:

Fed Concerns vs Earnings Optimism: Analysts Upgrade or Downgrade Barrick Gold, Spotify, Verizon and More
Monday’s additional top analyst upgrades and downgrades included Agilent Technologies, Barrick Gold, Deere, Kellogg, Marathon Oil, Newmont, Penn National Gaming, Spotify Technology and Verizon...
Chris Lange
Published:

5 Goldman Sachs Conviction List Stocks to Buy With 65% to 100% Upside Potential
Growth investors who are more aggressive and looking for Wall Street’s best ideas amid the current market uncertainties may want to consider these five Goldman Sachs Conviction List picks. If their...
Lee Jackson
Published:

Monday Afternoon's Analyst Upgrades and Downgrades: Activision Blizzard, BioMarin, eBay, Teladoc and More
Monday afternoon's analyst upgrades and downgrades included Activision Blizzard, BioMarin, eBay and Teladoc.
Chris Lange
Published:

Thursday’s Top Analyst Upgrades and Downgrades: AT&T, Alibaba, Ally Financial, BioMarin, Box, Citrix Systems, Five Below, Nio, TJX and More
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Baker Hughes, BioMarin, Cisco, Haliburton, Macy’s, Schlumberger, Sherwin-Williams and More
Thursday’s top analyst upgrades and downgrades included Baker Hughes, BioMarin Pharmaceutical, Cisco Systems, Haliburton, Macy’s, Schlumberger and Sherwin-Williams.
Chris Lange
Published:

Friday's Top Analyst Upgrades and Downgrades: BioMarin, Dick's Sporting Goods, Freeport-McMoRan, Northrop Grumman, Simon Properties, US Steel and More
Friday's top analyst upgrades and downgrades included ADS, BioMarin Pharmaceutical, Dick's Sporting Goods, Freeport-McMoRan, Northrop Grumman, Simon Properties and U.S. Steel.
Lee Jackson
Published:

Alexion, Activision, Baker Hughes and More Monday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
Chris Lange
Published:

Anthem, BioMarin, CRISPR, GE and More Thursday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Anthem, BioMarin, CRISPR, GE and more.
Chris Lange
Published:

BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon's Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas, Groupon, Sunrun, Twitter and more.
Chris Lange
Published:

Goldman Sachs Adds Pharmaceutical Giant to Conviction List of Top Stocks to Buy
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
Lee Jackson
Published:

7 Large Biotechs Expected to Outperform This Earnings Season
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: BioMarin, Checkpoint Software, Cinemark, Fortinet, Palo Alto, Regeneron, Shake Shack, Ventas, Zscaler and More
Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake Shack,...
Lee Jackson
Published: